ABSTRACT
In the synthesis and trafficking of precursors of most lysosomal matrix proteins, the stages necessary for lysosomal delivery include the addition of phosphorylated mannose-rich oligosaccharides, binding of the modified proteins to receptors, their segregation from the secretory pathways and delivery to the endosomal pathway. Targeting of both internally synthesized and externally provided enzymes (as in enzyme replacement therapy) to endosomes is executed by a complex machinery of membrane and cytosolic proteins. Recently, the homotypic fusion and vacuolar protein sorting (HOPS) complex has been identified in lysosomes from human cells. This complex is likely to play an important role in the exchange of enzymes between endosomal and lysosomal compartments. The present review describes the interactions and functions of proteins that participate in delivering lysosomal proteins to different lysosomal compartments. In summary, lysosomal trafficking depends on the recognition of many structural signals. It delivers soluble and membrane proteins, and can be exploited for therapeutic substitution of missing enzymes.
Subject(s)
Intracellular Signaling Peptides and Proteins/metabolism , Lysosomes/metabolism , Proteins/metabolism , Adaptor Proteins, Vesicular Transport/metabolism , Exocytosis/physiology , Humans , Lysosomal Storage Diseases/metabolism , Lysosomal Membrane Proteins/metabolism , Models, Biological , Protein TransportABSTRACT
To identify new genes that are upregulated during apoptosis we previously cloned rat pdcd4. While the role of pdcd4 is still unclear it seems to possess a tumor suppressor activity. Pdcd4 directly interacts with the RNA helicase eIF4A and inhibits protein synthesis by interfering with the assembly of the cap-dependent translation initiation complex. In the present study, we show that pdcd4 suppresses carbonic anhydrase type II protein expression in HEK293 and Bon-1 carcinoid cells. Since tumor cells require a high bicarbonate flux for their growth, carbonic anhydrase suppression results in growth inhibition. Similar to pdcd4, carbonic anhydrase inhibitor ethoxyzolamide reduces growth of several endocrine tumor cell lines. Thus, the translation inhibitor pdcd4 represses endocrine tumor cell growth by suppression of carbonic anhydase II. Furthermore, carbonic anhydrase inhibitors might represent promising tools for anti-endocrine tumor treatment.
Subject(s)
Carbonic Anhydrase II/antagonists & inhibitors , Endocrine Gland Neoplasms/pathology , RNA-Binding Proteins/physiology , Animals , Apoptosis Regulatory Proteins , Cell Division , Cell Line, Tumor , Cloning, Molecular , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Ethoxzolamide/pharmacology , Humans , RNA-Binding Proteins/genetics , Rats , TransfectionABSTRACT
The role of cathepsin D in stress-induced cell death has been investigated by using ovine fibroblasts exhibiting a missense mutation in the active site of cathepsin D. The cathepsin D (lysosomal aspartic protease) deficiency did not protect cells against toxicity induced by doxorubicin and other cytotoxic agents, neither did it protect cells from caspase activation. Moreover, the cathepsin D inhibitor, pepstatin A, did not prevent stress-induced cell death in human fibroblasts or lymphoblasts. The possible role of lysosomal ceramide or sphingosine-mediated activation of cathepsin D in apoptosis was also excluded by using human cells either overexpressing or deficient in acid ceramidase. However, a normal lysosomal function seems to be required for efficient cell death, as indicated by the finding that fibroblasts from patients with mucolipidosis II were partially resistant to staurosporine, sphingosine and TNF-induced apoptosis, suggesting a key role of lysosomes in cell death.
Subject(s)
Apoptosis , Cathepsin D/physiology , Lysosomes/enzymology , Acid Ceramidase , Amidohydrolases/genetics , Animals , Caspases/metabolism , Catalytic Domain , Cathepsin D/biosynthesis , Cathepsin D/genetics , Cathepsins/antagonists & inhibitors , Cells, Cultured , Ceramidases , Ceramides/metabolism , Doxorubicin/toxicity , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/metabolism , Humans , Mucolipidoses/pathology , Mutation, Missense , Pepstatins/pharmacology , Protease Inhibitors/pharmacology , Protein Transport , SheepABSTRACT
Insulin-like growth factor (IGF)-2 is overexpressed in hepatocellular carcinoma and accompanying dysplastic lesions. IGF-2 signalling is mediated through IGF-1 receptor (IGF-1R), while mannose 6-phosphate/insulin-like growth factor-2 receptor (M6P/IGF-2R) controls pericellular levels of free IGF-2. We studied, by in situ hybridisation and immunohistology, 18 liver specimens with cirrhosis of different aetiology without neoplastic or dysplastic lesions. Immunohistology was also performed for insulin receptor IGF-1R and IGF-binding proteins 3 and 4. High focal levels of IGF-2 RNA were found in some hepatocytes of all livers with HBV- or HCV-induced cirrhosis (n=10), but in only one of the cirrhoses with nonviral aetiology (n=8). IGF-2 was overexpressed in biliary duct epithelial cells in one case. Compared with noncirrhotic liver, all cirrhotic specimens showed reduced hepatocellular expression of M6P/IGF-2R protein, which contrasted with enhanced expression in perisinusoidal cells. Immunostaining for the other antigens did not reveal significant differences. Upregulation of IGF-2 in some hepatocytes may lead to high focal IGF-2 levels sufficient to saturate local IGF-2 binding capacities, and may result in an increased susceptibility to cellular dedifferentiation and, ultimately, liver cancer. Downregulation of hepatocellular M6P/IGF-2R and upregulation of IGF-2 seem to be early events in hepatocarcinogenesis prior to the appearance of morphologically distinct dysplastic lesions. Elevated focal IGF-2 transcript levels may therefore indicate an increased risk for hepatocellular and cholangiocellular carcinomas.
Subject(s)
Bile Ducts/metabolism , Hepatitis, Viral, Human/complications , Hepatocytes/metabolism , Insulin-Like Growth Factor II/metabolism , Liver Cirrhosis/metabolism , Bile Ducts/pathology , Humans , Immunohistochemistry , In Situ Hybridization , Liver Cirrhosis/etiologyABSTRACT
Exaggerated neutrophil responses are a critical component in the pathogenesis of periodontal disease. We investigated whether leukocyte activity in aggressive periodontitis (AP) is increased compared with that in chronic periodontitis (CP) by gingival crevicular fluid (GCF) analysis of myeloperoxidase (MPO), beta-N-acetyl-hexosaminidase (beta-NAH), cathepsin D (CD), and elastase-alpha-1-proteinase inhibitor complex (alpha-1-EPI) before and 6 months after therapy. Initial AP neutrophil responses were significantly amplified compared with those in CP (MPO, 3.2-fold; beta-NAH, 37.5-fold; CD, 2.2-fold; alpha-1-EPI, 1.4-fold; p < 0.05). Surgical therapy resulted in a significant reduction of GCF markers compared with non-surgical treatment. However, the changes in clinical parameters were not different between AP and CP (P > 0.05). Analysis of the results suggests that the local inflammatory response in AP is characterized by increased release of inflammatory mediators of neutrophil origin into the GCF. Analysis of the data further suggests that surgical therapy is a more predictable method for removal of the pro-inflammatory etiology.
Subject(s)
Gingival Crevicular Fluid/enzymology , Neutrophils/enzymology , Periodontitis/enzymology , Adult , Cathepsin D/analysis , Chronic Disease , Dental Plaque Index , Dental Scaling , Follow-Up Studies , Gingival Crevicular Fluid/cytology , Humans , Inflammation Mediators/analysis , Leukocyte Elastase/analysis , Middle Aged , Neutrophils/physiology , Periodontal Attachment Loss/enzymology , Periodontal Attachment Loss/surgery , Periodontal Attachment Loss/therapy , Periodontal Index , Periodontal Pocket/enzymology , Periodontal Pocket/surgery , Periodontal Pocket/therapy , Periodontitis/classification , Periodontitis/surgery , Periodontitis/therapy , Peroxidase/analysis , Root Planing , Serine Proteinase Inhibitors/analysis , Statistics, Nonparametric , alpha 1-Antitrypsin/analysis , beta-N-Acetylhexosaminidases/analysisABSTRACT
OBJECTIVES: In the present prospective trial, the PMN response following resorbable GTR barrier placement was evaluated in mandibular class II furcation lesions. MATERIALS AND METHODS: In 10 patients with treated chronic periodontitis, we randomly selected the 1st molars in the mandible with buccal degree II furcation involvement for either polylactic-citric-acid-ester (PLA) or glycolide-lactic-copolymer (PGL) GTR membrane therapy. We examined contralateral healthy molar sites as untreated controls. We then evaluated the PMN-derived inflammatory tissue response at baseline, weekly up to 6 weeks post-therapy and at 12 and 24 weeks using GCF myeloperoxidase (MPO), beta-glucuronidase (betaG) and beta-N-acetyl-hexosaminidase (betaNAH). RESULTS: The enzyme levels increased from baseline to the 6-week examination. After the 6-week reappointment, enzyme levels dropped reaching the baseline scores at both the 12- and 24-week visit. At PGL sites, the enzyme levels decreased earlier. Compared with healthy control sites, the MPO, betaNAH and betaG tests revealed different maximum levels at week 2 and 3 (PGL) and week 4, 5 and 6 (PLA). For both of the barriers the clinical parameters revealed a sustained improvement following therapy. CONCLUSION: The release of PMN enzymes following placement of bioabsorbable membranes reflects the early soft tissue healing process. Our results suggest that the PMN response is barrier-dependent with the maximum response occuring at different times. However, the host response did not measureably affect the course of clinical healing.
Subject(s)
Absorbable Implants , Guided Tissue Regeneration, Periodontal/instrumentation , Membranes, Artificial , Neutrophils/physiology , Chronic Disease , Dental Plaque Index , Female , Follow-Up Studies , Furcation Defects/classification , Furcation Defects/surgery , Gingival Crevicular Fluid/cytology , Gingival Crevicular Fluid/enzymology , Glucuronidase/analysis , Humans , Lactic Acid , Male , Mandibular Diseases/classification , Mandibular Diseases/surgery , Middle Aged , Neutrophils/enzymology , Periodontal Attachment Loss/surgery , Periodontal Index , Periodontal Pocket/surgery , Periodontitis/surgery , Peroxidase/analysis , Polyesters , Polyglycolic Acid , Polylactic Acid-Polyglycolic Acid Copolymer , Polymers , Prospective Studies , Statistics, Nonparametric , Wound Healing , beta-N-Acetylhexosaminidases/analysisABSTRACT
Human promonocytes U937 synthesize lysozyme and retain approximately one third of it within lysosomes. Lysozyme is not glycosylated; thus, it cannot be subject to mannose-6-phosphate-dependent targeting to lysosomes. It is a basic protein with a pI of 10.5 and is known to interact with negatively charged macromolecules like proteoglycans. Therefore, we examined whether the latter are involved in the lysosomal targeting of lysozyme in U937 cells. We partially diminished the electronegative charge of newly synthesized proteoglycans by inhibiting their sulfation with chlorate. This increased the rate of secretion of lysozyme. Upon treatment of U937 cells with phorbol esters, the rate of secretion of lysozyme was increased to more than 90%. This coincided with an almost complete redistribution of a [(35)S]sulfate bearing proteoglycan to the secretory pathway. After a brief pulse with [(35)S]sulfate in the control, 80% of the [(35)S]sulfate-bearing proteoglycan was retained within the cells, whereas in the treated cells this proportion was decreased to 13%. The secreted proteoglycan was sensitive to chondroitinase ABC and bound to immobilized lysozyme. This interaction was disrupted by 50-300 mM NaCl. The intracellularly retained proteoglycan was degraded with a half-life of 50-60 minutes and seemed to be directed to lysosomes because in the presence of NH(4)Cl the degradation was strongly inhibited. Our results suggest that the proteoglycan is involved in lysosomal targeting of lysozyme in U937 cells.
Subject(s)
Chondroitin Sulfates/metabolism , Lysosomes/metabolism , Muramidase/metabolism , Ammonium Chloride/pharmacology , Chondroitin ABC Lyase , Chondroitin Sulfates/biosynthesis , Chondroitin Sulfates/isolation & purification , Chromatography, Affinity , Enzymes, Immobilized/chemistry , Enzymes, Immobilized/metabolism , Humans , Kinetics , Lysosomes/drug effects , Mannosephosphates/metabolism , Muramidase/chemistry , Perchlorates/pharmacology , Protein Binding , Protein Transport , Proteoglycans/metabolism , Sodium Compounds/pharmacology , Sulfates/metabolism , Sulfur Radioisotopes , Tetradecanoylphorbol Acetate/pharmacology , U937 CellsABSTRACT
We have studied the elongation of oligosaccharides containing N-acetyl-lactosamine repeats using glycosylated human lysozyme mutants as a model. We reported previously that a combination of glycosylation sites at the 49th (site IV) and 68th (site II) amino acid residues of the protein particularly stimulates the synthesis of N-acetyl-lactosamine repeats [Melcher, Grosch, Grosse and Hasilik (1998) Glycoconjugate J. 15, 987-993]. In the present study we show that it is the carbohydrate attached to site IV that is selectively affected. It contains more N-acetyl-lactosamine repeats when site II is glycosylated in the same molecule. As a corollary of the glycosylation at site II, the synthesis of a third antenna at site IV is increased. The triantennary oligosaccharides at site IV contain more N-acetyl-lactosamine repeats than the biantennary ones. Thus placing a carbohydrate at site II stimulates the branching and the elongation of the carbohydrate at the other site.
Subject(s)
Amino Sugars/chemistry , Muramidase/metabolism , Oligosaccharides/chemistry , Amino Acid Sequence , Amino Sugars/chemical synthesis , Animals , CHO Cells , Chromatography, High Pressure Liquid , Cricetinae , Glycopeptides/chemistry , Glycopeptides/isolation & purification , Glycosylation , Humans , Molecular Sequence Data , Muramidase/chemistry , Spectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationABSTRACT
It has been reported that besides defects in the phosphorylation such as in the I-cell disease, a failure in the uncovering of mannose 6-phosphate residues may result in an increase of lysosomal enzyme activities in serum [Alexander et al., Hum. Genet. 73, 53-59 (1986)]. We examined fibroblasts that were derived from the original biopsy, observed an enhanced secretion of lysosomal enzymes including cathepsin D, but found that both the phosphorylation and uncovering of mannose 6-phosphate residues were normal. The enhanced secretion of cathepsin D was characterized by an increase in the secretion of phosphorylated molecules that were sensitive to a treatment with alkaline phosphatase. The enhanced secretion of the phosphatase-sensitive form of procathepsin D was further increased in the presence of antibodies directed to cation-independent mannose 6-phosphate receptors. In contrast, antibodies specific to cation-dependent mannose 6-phosphate receptors selectively inhibited the secretion of the phosphatase-sensitive procathepsin D molecules. A chromatographic analysis of oligosaccharides from the secreted procathepsin D confirmed that the cells secrete proenzyme molecules rich in oligosaccharides with two uncovered phosphate residues. It is suggested that the enhanced secretion of procathepsin D in the variant fibroblasts results from an abnormal sorting rather than processing of phosphorylated lysosomal enzymes.
Subject(s)
Cathepsin D/metabolism , Enzyme Precursors/metabolism , Cell Line , Humans , Lysosomes/enzymology , Phosphates/metabolism , Receptor, IGF Type 2/physiology , beta-N-Acetylhexosaminidases/metabolismABSTRACT
The role of the N-terminal sequence of myeloperoxidase in the intracellular targeting was examined by using glycosylated lysozyme as a reporter. A fusion protein was constructed in which the presequence residues-18 through -6 of the lysozyme moiety had been replaced by residues 1-158 of prepromyeloperoxidase. Expression of the fusion protein in Chinese hamster ovary cells demonstrated its partial secretion and partial intracellular retention. The latter was accompanied by trimming the myeloperoxidase prosequence off the lysozyme moiety. The rate of the retention of the lysozyme fusion protein was higher than that of glycosylated lysozyme that had been expressed in cells transfected with cDNA of glycosylated lysozyme. The retention was insensitive to NH4Cl. In the secreted protein, lysozyme contained predominantly complex oligosaccharides as demonstrated by a proteolytic fragmentation in vitro and resistance to endo-beta-N-acetylglucosaminidase H. In contrast, when targeted to lysosomes, the lysozyme moiety of the fusion protein contained predominantly mannose-rich oligosaccharides. In baby hamster kidney cells, the trimming of the oligosaccharides in the lysozyme fragment was less vigorous, and a selective targeting of molecules bearing mannose-rich oligosaccharides to lysosomes was more apparent than in Chinese hamster ovary cells. In the presence of monensin, the formation of complex oligosaccharides in the fusion protein and its secretion were strongly inhibited, whereas the intracellular fragmentation was not. We suggest that the prosequence of myeloperoxidase participates in the intracellular routing of the precursor and that this routing operates on precursors bearing mannose-rich rather than terminally glycosylated oligosaccharides and diverts them from the secretory pathway at a site proximal to the monensin-sensitive compartment of the Golgi apparatus.
Subject(s)
Glycoproteins/metabolism , Lysosomes/metabolism , Mannose/metabolism , Peroxidase/metabolism , Animals , CHO Cells , Cell Line , Cricetinae , Glycoproteins/chemistry , Humans , Protein Processing, Post-Translational , Recombinant Fusion Proteins/metabolismSubject(s)
Baculoviridae/genetics , Cloning, Molecular/methods , Cysteine Endopeptidases/metabolism , Genetic Vectors/metabolism , Recombinant Proteins/biosynthesis , Recombinant Proteins/metabolism , Animals , Cell Line , Humans , Hydrolysis , Protein Precursors/biosynthesis , Protein Precursors/genetics , Protein Precursors/metabolism , Spodoptera/genetics , Spodoptera/virologyABSTRACT
BHK cells transfected with human cathepsin D (CD) cDNA normally segregate the autologous hamster cathepsin D while secreting a large proportion of the human proenzyme. In the present work, we have utilized these transfectants to examine to what extent the mannose-6-phosphate-dependent pathway for lysosomal enzyme segregation contributes to the differential sorting of human and hamster CD. We report that, in recipient control BHK cells, the rate of mannose-6-phosphate-dependent endocytosis of human procathepsin D secreted by transfected BHK cells is lower than that of hamster procathepsin D and much lower than that of human arylsulphatase A. The missorted human enzyme bears phosphorylated oligosaccharides and most of its phosphate residues are "uncovered", like the autologous enzyme. Thus, despite both the Golgi-associated modifications of oligosaccharides, i.e. the phosphorylation of mannose and the uncovering of mannose-6-phosphate residues, which proceed on human and hamster procathepsin D with comparable efficiency, only the latter is accurately packaged into lysosomes. Ammonium chloride partially affects the lysosomal targeting of cathepsin D in control BHK cells, whereas in transfected cells, this drug strongly inhibits the maturation of human procathepsin D and slightly enhances its secretion. These data indicate that: (1) over-expression of a lysosomal protein does not saturate the Golgi-associated reactions leading to the synthesis of mannose-6-phosphate; (2) a portion of cathepsin D is targeted independently of mannose-6-phosphate receptors in the transfected BHK cells; and (3) whichever mechanism for lysosomal delivery of autologous procathepsin D is involved, this is not saturated by the high rate of expression of human cathepsin D.
Subject(s)
Cathepsin D/metabolism , Endocytosis , Enzyme Precursors/metabolism , Lysosomes/metabolism , Receptor, IGF Type 2/metabolism , Ammonium Chloride/pharmacology , Animals , Cathepsin D/genetics , Cell Line , Cricetinae , Enzyme Precursors/genetics , Humans , Lysosomes/drug effects , Mannosephosphates/genetics , Mannosephosphates/metabolism , Phosphorus Radioisotopes , Phosphorylation , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Species Specificity , Sulfur Radioisotopes , TransfectionABSTRACT
Tissue injury and inflammation in inflammatory bowel disease (IBD) are associated with enhanced monocytic lysosomal enzyme release. In this study, peripheral monocytes and lamina propria mononuclear cells (LPMNC) were isolated from IBD patients and normal controls. Cells were stimulated with lipopolysaccharide after treatment with IL-13, IL-4, and IL-10, and enzyme secretion was assessed by using the corresponding p-nitrophenyl glycosides as substrates. Molecular forms of cathepsin D were examined to describe the mode of enzyme release. IL-10 and IL-4 strongly down-regulate enzyme secretion in IBD monocytes. IBD monocytes showed a diminished responsiveness to the inhibitory effect of IL-13. Impaired monocyte response was not found with combinations of IL-13 and IL-10 or IL-4 and IL-10. LPMNC from involved IBD mucosa showed significantly higher enzyme secretion compared with LPMNC from noninvolved IBD mucosa but responded inefficiently to either IL-4, IL-13, or IL-10 alone. However, combined treatment with IL-10 and IL-4 or IL-10 and IL-13 strongly suppressed enzyme release by these cells. Both the precursor and mature forms of cathepsin D were elevated in IBD patients. While IL-13 reduced mainly the precursor form, the effect of IL-4 and IL-10 concerns both the precursor and mature form of cathepsin D. Our results favor the potent clinical utility of combined treatment, thus improving chances of developing effective treatments for human IBD.
Subject(s)
Colitis, Ulcerative/enzymology , Crohn Disease/enzymology , Interleukin-10/pharmacology , Interleukin-13/pharmacology , Interleukin-4/pharmacology , Monocytes/enzymology , Adult , Case-Control Studies , Cathepsin D/metabolism , Colitis, Ulcerative/pathology , Colon/pathology , Crohn Disease/pathology , Down-Regulation , Female , Glucuronidase/metabolism , Humans , Intestinal Mucosa/pathology , Lipopolysaccharides/pharmacology , Male , Mannosidases/metabolism , Monocytes/drug effects , alpha-Mannosidase , beta-Galactosidase/metabolism , beta-N-Acetylhexosaminidases/metabolismABSTRACT
A method for the purification of lysosomes from fibroblasts has been developed which uses endocytosis of superparamagnetic colloidal iron dextran particles followed by separation of the iron-containing lysosomes in a magnetic field. This permitted isolation of lysosomes from fibroblasts from patients with infantile sialic acid storage disorder and other lysosomal storage diseases in which a shift in lysosomal density induced by the storage material prevents purification by centrifugation in a Percoll gradient. The magnetic lysosomes isolated from these cells are very similar to those from normal cells as judged by lysosomal marker enzyme activity and 2D-PAGE analysis of the enriched proteins.
Subject(s)
Chromatography, Affinity/methods , Lysosomal Storage Diseases/pathology , Lysosomes , N-Acetylneuraminic Acid/metabolism , Cell Fractionation , Cells, Cultured , Dextrans/chemistry , Dextrans/metabolism , Electrophoresis, Gel, Two-Dimensional , Endocytosis , Fibroblasts , Humans , Iron/chemistry , Magnetics , Mitochondria/metabolismABSTRACT
Lysozyme is an example of an extensively studied secretory enzyme. Glycosylated mutant human lysozyme has been used as a model in studies on the biosynthesis of N-acetyllactosamine repeats in N-linked oligosaccharides. We examined the biosynthesis of the repeats in two doubly glycosylated mutants and describe here a rapid purification and separation of singly and doubly glycosylated molecules. In one of the mutants, the elongation of the repeats is enhanced if the molecules are doubly glycosylated, but not if the carbohydrate is attached to either site individually. This enhancement is not seen in the other doubly glycosylated mutant. Since lysozyme is not structurally related to glycoproteins bearing carbohydrate with N-acetyllactosamine repeats, we propose that in multivalent substrates the synthesis of the repeats can be promoted by a proper spacing of the elongated carbohydrate antennae in addition to any role of the protein backbone.
Subject(s)
Amino Sugars/metabolism , Muramidase/metabolism , Amino Sugars/chemistry , Amino Sugars/genetics , Animals , Base Sequence , Binding Sites , CHO Cells , Cricetinae , DNA Primers , Glycosylation , Humans , Models, Chemical , Muramidase/chemistry , Mutagenesis, Site-DirectedABSTRACT
Glycosylated [Asn22]lysozyme has been shown to contain N-acetyllactosamine repeats when expressed in chinese hamster ovary (CHO) cells. We find that the major portion of N-acetyllactosamine repeats are associated with diantennary oligosaccharides. In Lec2 CHO cells, which are deficient in sialylation, glycosylated lysozyme is synthesized with increased contents of N-acetyllactosamine repeats terminating in beta-galactosyl residues. In the Lec2 cells and the parental CHO cell line, Pro 5, only a minor portion of the oligosaccharides in lysozyme are of the triantennary type. Previously, it has been shown that the synthesis of N-acetyllactosamine repeats in Asn-linked oligosaccharides is enhanced by an increase in the activity of the elongating beta-N-acetylglucosaminyl transferase and by the synthesis of beta-1,6-linked antennae. The results with glycosylated lysozyme suggest that glycoproteins bearing diantennary oligosaccharides can contain several N-acetyllactosamine repeats and that the number of the latter can be increased by decreasing the activity of the capping sialyl transferases.
Subject(s)
Amino Sugars/chemistry , Bacterial Proteins , Muramidase/metabolism , Oligosaccharides/chemistry , Animals , Asparagine , CHO Cells , Carbohydrate Sequence , Cricetinae , Glycine , Glycoside Hydrolases/metabolism , Glycosylation , Humans , Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase/metabolism , Muramidase/chemistry , N-Acetylneuraminic Acid/metabolismABSTRACT
Synthesis, processing and sorting of pro-cathepsin D (proCD), the precursor of a lysosomal protease involved in tumor-cell proliferation and invasion, were compared in various human tumor cell lines. In cultures of HepG2, HT29 and MCF7 cells the extracellular CD activity was up to 10 times higher than in cultures of U937 and MG63 cells. Ammonium chloride, which disrupts the pH-dependent receptor-mediated transport of lysosomal enzymes, exerted a differential effect on the secretion of CD activity in these cells. As judged by metabolic labeling and immunoprecipitation, the secretion of CD synthesized in 24 hr in MG63 and U937 cells was enhanced 4- to 10-fold by ammonium chloride, while it was only slightly increased in HepG2, HT29 and MCF7 cells. In all tumor cells examined, a portion of proCD was segregated into the endosomal-lysosomal pathway in the presence of ammonium chloride. However, the intralysosomal maturation of CD was only inhibited by this drug in HT29 and MCF7 cells. The Golgi-associated processing of proCD, leading to the synthesis of uncovered phosphomannosyl groups, proceeded with comparable efficiency in all tumor cells examined. These results suggest that hypersecretion of proCD in HepG2, HT29 and MCF7 cells is linked to transport mechanisms, as yet unidentified, which are independent of mannose-6-phosphate.
Subject(s)
Cathepsin D/metabolism , Enzyme Precursors/metabolism , Mannose/metabolism , Neoplasm Proteins/metabolism , Neoplasms/metabolism , Acetylglucosamine/analogs & derivatives , Acetylglucosamine/metabolism , Ammonium Chloride/pharmacology , Enzyme Activation/drug effects , Humans , Lysosomes/metabolism , Phosphorylation , Tumor Cells, CulturedABSTRACT
The tissue distribution, preferentially in the human male genital system, and the subcellular localization of the lysosome-associated membrane protein 2 (lamp 2) was studied immunohistochemically using a mouse monoclonal antibody, 2D5. Strong immunoreactivity was present in the tubular system of the kidney, in acinar cells of salivary glands and pancreas, prostate, mammary glands, placenta and in cutaneous sweat glands. Moderate immunoreactivity was observed in cerebral neuronal cells, epidermal cells, testis, epididymis, seminal vesicle and endometrium. Very low immunoreactivity was found in liver. In some of the tissues mentioned, the distribution pattern of immunoreactivity is smooth and homogeneous, while in others it is granular and concentrated in the supra- or perinuclear cytoplasm. The subcellular distribution was studied on ultracryosections and on pre-embedding-processed chopper sections of human prostate. In the latter gland, the protein is not restricted to epithelium, but is also present in stromal cells. Ultrastructurally, the immunoreactivity in secretory cells was localized in electron-translucent vacuoles and granules, including the secretory granules. A close association with cell membranes was not generally the case. Only part of the immunoreactive material was linked to the apical plasma membrane pointing to a biosynthesis independent from an association step with the apical plasma membrane. As shown by immunoelectron microscopy and Western blotting, a high amount of lamp 2 is secreted and is found in so-called prostasomes. The findings indicate that in the human prostate most of the membrane-bound lamp 2 is released from the secretory cells, presumably in an apocrine fashion.
Subject(s)
Antigens, CD/analysis , Genitalia, Male/chemistry , Lysosomes/chemistry , Membrane Glycoproteins/analysis , Animals , Antibodies, Monoclonal/immunology , Antigens, CD/immunology , Antigens, CD/physiology , Antigens, Neoplasm/analysis , Antigens, Surface/analysis , Blotting, Western , Breast/chemistry , Cell Polarity , Cytoplasmic Granules/chemistry , Endometrium/chemistry , Female , Glutamate Carboxypeptidase II , Humans , Liver/chemistry , Lysosomal Membrane Proteins , Male , Membrane Glycoproteins/immunology , Membrane Glycoproteins/physiology , Mice , Microscopy, Immunoelectron , Organ Specificity , Placenta/chemistry , Prostate/chemistry , Prostate/metabolism , Prostate/ultrastructure , Salivary Glands/chemistry , Subcellular Fractions/chemistry , Sweat Glands/chemistry , Vacuoles/chemistryABSTRACT
The kinetics of transport and the processing of procathepsin D (proCD), the precursor of a lysosomal aspartyl protease involved in tumor-cell proliferation and metastasis, were compared in normal and SV-40- or benzo[a]pyrene-transformed 3T3 mouse fibroblasts. Sorting of newly synthesized proCD in normal cells was almost complete within 3 hr, while in transformed cells a fraction of the precursor survives a long time. In both normal and transformed 3T3 cultures, secretion of proCD started at 3 hr of chase. However, in normal cells secretion of proCD remained constant between 3 and 24 hr of chase, while in transformed cells it increased along with the chase incubation. The efficiency of formation of the mannose-6-phosphate group on proCD varied among the 3 cell types, being minimal in benzo[a]pyrene-transformed 3T3 cells. Ammonium chloride, a drug known to disrupt the segregation and to enhance the secretion of lysosomal proenzymes, was 2-fold more effective in normal than in transformed 3T3 cells. Despite vacuolar alkalinization, about one third of proCD was segregated into the endosomal-lysosomal pathway in normal and in transformed 3T3 fibroblasts, indicating the existence in these cells of alternative, mannose-6-phosphate receptor-independent mechanisms for targeting proCD. Thus, while hypersecretion of proCD and reduced sensitivity to vacuolar alkalinization are common features of both transformed cell types, the mechanisms responsible for inefficient segregation of proCD may differ between virally and chemically transformed 3T3 cells.
Subject(s)
3T3 Cells/metabolism , Cathepsin D/metabolism , Enzyme Precursors/metabolism , Mannosephosphates/metabolism , Ammonium Chloride/pharmacology , Animals , Biological Transport/drug effects , Cell Line, Transformed , Mice , PhosphorylationABSTRACT
The small dermatan sulfate proteoglycans decorin and biglycan are efficiently internalized by a variety of cells of mesenchymal origin. This process is modulated, at least under tissue culture conditions, by cell surface-associated heparan sulfate proteoglycans. Receptor proteins of 51 and 26 kDa, respectively, bind to leucine-rich repeat structures of the core proteins of the small proteoglycans but also to highly sulfated domains of heparan sulfate. The 51 kDa protein was purified from rat brain tissue by subcellular fractionation, heparin affinity chromatography and subsequent SDS-PAGE, and was used for raising a polyclonal antiserum. Affinity-purified antibodies also recognize the 26 kDa protein and a few other low molecular weight proteins, suggesting that these proteins represent proteolytic degradation products of the 51 kDa receptor. By confocal laser microscopy, it could be demonstrated that the affinity-purified antibody reacted at 0 degree C with a protein that became internalized and was transported to a perinuclear compartment during 15 min of incubation at 37 degrees C. These findings provide direct evidence that the receptor protein(s) are internalized together with the ligand and reach an endosomal compartment where further sorting can occur.